GALECTIN THERAPEUTICS INC Annual Interest Expense in USD from 2017 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Galectin Therapeutics Inc quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
Galectin Therapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $1.05M, a 129% increase year-over-year.
Galectin Therapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $3.38M, a 167% increase year-over-year.
Galectin Therapeutics Inc annual Interest Expense for 2023 was $2.79M, a 170% increase from 2022.
Galectin Therapeutics Inc annual Interest Expense for 2022 was $1.03M, a 111% increase from 2021.
Galectin Therapeutics Inc annual Interest Expense for 2021 was $489K, a 462% increase from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$2.79M	+$1.76M	+170%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-29
2022	$1.03M	+$544K	+111%	Jan 1, 2022	Dec 31, 2022	10-K	2024-03-29
2021	$489K	+$402K	+462%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-30
2020	$87K	$0	0%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-31
2019	$87K	-$249K	-74.1%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-31
2018	$336K	+$324K	+2700%	Jan 1, 2018	Dec 31, 2018	10-K	2020-03-16
2017	$12K			Jan 1, 2017	Dec 31, 2017	10-K	2019-03-06

Showing 1 to 7 of 7 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.